← Leaderboards
Paul J Chiao
University Of Texas Md Anderson Can Ctr
$8,649,694
Attributed
$8,986,739
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $880.7K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,986,739 · 9
By mechanism
R01$7,841,787 · 5
U01$505,567 · 1
R21$329,044 · 2
R29$310,341 · 1
Top collaborators
- Dmitri Lapotko1 shared
- Vladimir P Torchilin1 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Bingliang Fang$8,920,662
- Mien-Chie Hung$10,660,923
- Donghui Li$4,233,878
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineSurvival RateCellsBasePancreasPhosphotransferasesDiagnosisMouse ModelMalignant Neoplasm Of PancreasMutationMutantMolecularPlayMediatingSignal TransductionAnticancer ResearchMalignant NeoplasmsOverexpressionSignal PathwayIn VivoPancreatic NeoplasmAdultCancer Cell LineCancer Cell
Grant awards (36)
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma$366,000
R01 · FY2021 · CA · contact PI
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma$366,000
R01 · FY2020 · CA · contact PI
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma$355,019
R01 · FY2019 · CA · contact PI
Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance$505,567
U01 · FY2018 · CA
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma$366,000
R01 · FY2018 · CA · contact PI
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma$366,000
R01 · FY2017 · CA · contact PI
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer$308,475
R01 · FY2014 · CA · contact PI
Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis$308,474
R01 · FY2014 · CA · contact PI
Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis$298,935
R01 · FY2013 · CA · contact PI
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer$298,934
R01 · FY2013 · CA · contact PI
Mechanisms of RelA Activation in Cancer$205,159
R01 · FY2013 · CA · contact PI
Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis$318,015
R01 · FY2012 · CA · contact PI
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer$318,015
R01 · FY2012 · CA · contact PI
Mechanisms of RelA Activation in Cancer$218,253
R01 · FY2012 · CA · contact PI
Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis$318,015
R01 · FY2011 · CA · contact PI
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer$318,015
R01 · FY2011 · CA · contact PI
Mechanisms of RelA Activation in Cancer$218,253
R01 · FY2011 · CA · contact PI
Mechanisms of Overexpressed TrkB in Inducing Pancreatic Cancer Metastasis$327,850
R01 · FY2010 · CA · contact PI
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer$327,850
R01 · FY2010 · CA · contact PI
Mechanisms of RelA Activation in Cancer$225,003
R01 · FY2010 · CA · contact PI
Mechanisms of RelA Activation in Cancer$225,003
R01 · FY2009 · CA · contact PI
Mechanisms of Tumorigenesis in Pancreatic Epithelial Cells$183,474
R01 · FY2009 · CA · contact PI
Mechanisms of Tumorigenesis in Pancreatic Epithelial Cells$183,474
R01 · FY2008 · CA · contact PI
Mechanisms of Tumorigenesis in Pancreatic Epithelial Cells$183,474
R01 · FY2007 · CA · contact PI
Validation of potential early diagnostic and prognostic markers for pancreatic ca$110,694
R21 · FY2007 · CA · contact PI
Mechanism of RelA activation in Pancreatic cancer$210,118
R01 · FY2006 · CA · contact PI
Mechanisms of Tumorigenesis in Pancreatic Epithelial Cells$188,954
R01 · FY2006 · CA · contact PI
Validation of potential early diagnostic and prognostic markers for pancreatic ca$114,000
R21 · FY2006 · CA · contact PI
Mechanism of RelA activation in Pancreatic cancer$215,175
R01 · FY2005 · CA
Mechanism of Tumorigenesis in Pancreatic Epithelial Cell$193,500
R01 · FY2005 · CA
Mechanism of RelA activation in Pancreatic cancer$215,175
R01 · FY2004 · CA
Mechanism of RelA activation in Pancreatic cancer$215,175
R01 · FY2003 · CA
THE ROLE OF RE1A IN HUMAN ADENOCARCINOMA OF PANCREAS$103,447
R29 · FY2002 · CA
THE ROLE OF RE1A IN HUMAN ADENOCARCINOMA OF PANCREAS$102,692
R29 · FY2001 · CA
FUNCTION OF NFKB IN CANCER METASTASIS$104,350
R21 · FY2000 · CA
THE ROLE OF RE1A IN HUMAN ADENOCARCINOMA OF PANCREAS$104,202
R29 · FY2000 · CA